RAPT THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.155 USD | -5.57% |
|
-48.39% | -83.22% |
| 01:19pm | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
| May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPT THERAPEUTICS, INC. | Bio Therapeutic Drugs | -5.23% | -48.39% | -83.22% | -80.46% | - | 154M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RAPT Stock
- Charts RAPT Therapeutics, Inc.
- Comparison Chart
